GUENTHER, Lyn et al. Ixekizumab Results in Persistent Clinical Improvement in Moderate-to-Severe Genital Psoriasis During a 52 Week, Randomized, Placebo-Controlled, Phase 3 Clinical Trial. Acta Dermato-Venereologica, [S. l.], v. 100, n. 1, p. 1–9, 2020. DOI: 10.2340/00015555-3353. Disponível em: https://medicaljournalssweden.se/actadv/article/view/1629. Acesso em: 19 oct. 2024.